SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Ironwood Pharmaceuticals, Inc. backtest

10 trend-following strategies were compared on the full daily history of Ironwood Pharmaceuticals, Inc.. 9 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is ADX / DI 방향성 (CAGR 10.7%, MDD -19.2%).

Data 2010-02-03 ~ 2026-07-31daily bars 4,148 (16.5 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

9 of 10 beat buy and hold (CAGR -5.0%, drawdown -96.8%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 10.7%, MDD -19.2%, Sharpe 0.59, 6% exposure.

Return/drawdown alternative: ADX / DI 방향성 — CAGR is 15.7%p higher than buy and hold, while drawdown improves by 77.6%p (CAGR 10.7%, MDD -19.2%, exposure 6%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=15, threshold=36
10.7%-19.2%0.590.565.3x166%
볼린저 밴드 돌파
n=48, k=3.4
9.7%-26.9%0.530.364.6x108%
Keltner 채널 돌파
emaPeriod=55, atrPeriod=12, mult=3.8
5.4%-47.4%0.340.112.4x1612%
SMA 크로스오버
fast=33, slow=71
0.7%-78.5%0.200.011.1x7147%
Donchian 채널 돌파
entryN=81, exitN=21
1.3%-75.5%0.190.021.2x4027%
Parabolic SAR
step=0.01, maxStep=0.3
-3.2%-86.2%0.09-0.040.6x22248%
Supertrend
period=11, mult=2.5
-4.0%-93.1%0.09-0.040.5x14049%
EMA 크로스오버
fast=41, slow=99
-3.2%-88.3%0.08-0.040.6x4342%
ROC 모멘텀
n=57, threshold=0.05
-3.9%-90.5%0.04-0.040.5x25037%
MACD
fast=19, slow=56, signal=13
-9.5%-98.1%-0.04-0.100.2x19450%
Buy and hold-5.0%-96.8%0.19-0.050.4x1100%
0.1 1x 2011 2013 2015 2017 2019 2021 2023 2025 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -24% -48% -73% -97% 2011 2013 2015 2017 2019 2021 2023 2025 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -19.2% (2025-10-09 → 2025-10-17), recovered after 22 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next